January 2023
176 articles-
Jan 31 · 04:45Biotechnology Daily
A receptor found on gut cells is present on immune cells, too, opening the door to new approaches to treat IBD
-
Jan 31 · 04:44Biotechnology Daily
Madrigal's stock enters orbit after 2nd phase 3 NASH success sets up FDA filing
-
Jan 31 · 04:43Biotechnology Daily
Moon Surgical sets up robotic assistant launch with FDA clearance, first-in-human study
-
Jan 31 · 04:41Biotechnology Daily
Google aims to translate hand-scribbled doctors' notes and prescriptions using AI
-
Jan 31 · 04:40Bio Business News
Bionomics' lead asset fails to reduce public speaking anxiety in phase 2 trials
-
Jan 31 · 04:39Bio Business News
Velocity celebrates Meridian acquisition as creating world's largest research site organization
-
Jan 31 · 04:38Bio Business News
Devicemakers cutting products in the EU due to rising costs, slowed regulations
-
Jan 31 · 04:36Bio Business News
Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers
-
Jan 30 · 09:21Biotechnology Daily
Alnylam culls 3 programs, including nephropathy med that was slated for phase 3
-
Jan 30 · 09:20Biotechnology Daily
MedCognetics scores FDA green light for breast cancer screening AI
-
Jan 30 · 09:19Biotechnology Daily
Synaptogenix's Alzheimer's prospect flops in NIH-sponsored study, sinking stock
-
Jan 30 · 09:18Bio Business News
Pfizer links up with heart disease AI developer Anumana to build cardiac amyloidosis diagnostics
-
Jan 30 · 09:16Bio Business News
Astellas' 2nd phase 3 win in a month for cancer antibody tees up submissions to regulators
-
Jan 30 · 09:15Bio Business News
Siemens, GE considering buying up Medtronic segments slated for spinout: Bloomberg
-
Jan 30 · 09:14Bio Business News
J&J-partnered Sonnet halts work on bispecific while hunting for fresh collaborators
-
Jan 30 · 09:13Bio Business News
Lilly pens $730M biobucks deal with Sosei Heptares to get in on GPCR action
-
Jan 26 · 22:42Biotechnology Daily
Third Harmonic, latest victim of raised liver enzymes, shutters trial and sees shares slide
-
Jan 26 · 22:41Biotechnology Daily
Sio confirms gene therapy company will be liquidated after tough year
-
Jan 26 · 22:40Biotechnology Daily
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
-
Jan 26 · 22:39Biotechnology Daily
Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data
-
Jan 26 · 22:38Bio Business News
Axonics nabs Canadian nod for 20-year incontinence implant requiring fewer recharges
-
Jan 26 · 22:37Bio Business News
Gates, Bezos back $75M round for Synchron's drill-free brain-computer interface implant
-
Jan 26 · 22:35Bio Business News
45 days later, BioCryst abandons another program, citing stiff competition
-
Jan 26 · 22:34Bio Business News
Innovent plucks Chinese rights to LG Chem's gout disease treatment in nearly $100M deal